![]() |
Volumn 3, Issue 7, 2011, Pages 2844-2848
|
Triggered release of therapeutic antibodies from nanodiamond complexes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CURRENT LIMITATION;
DETONATION NANODIAMONDS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
NANO DIAMOND;
PH LEVELS;
PHARMACOLOGICAL AGENTS;
PHYSIOLOGICAL CONDITION;
SALINE SOLUTIONS;
THERAPEUTIC ANTIBODIES;
THERAPEUTIC APPLICATION;
TRANSFORMING GROWTH FACTORS;
TRIGGERED RELEASE;
UV-VIS SPECTROSCOPY;
ADSORPTION;
BODY FLUIDS;
DESORPTION;
DIAMONDS;
DRUG DELIVERY;
ULTRAVIOLET SPECTROSCOPY;
ANTIBODIES;
ANTIBODY;
DRUG CARRIER;
NANODIAMOND;
TRANSFORMING GROWTH FACTOR BETA;
ADSORPTION;
ARTICLE;
CHEMISTRY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
IMMUNOLOGY;
PH;
ULTRASTRUCTURE;
ULTRAVIOLET SPECTROPHOTOMETRY;
ADSORPTION;
ANTIBODIES;
DRUG CARRIERS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HYDROGEN-ION CONCENTRATION;
NANODIAMONDS;
SPECTROPHOTOMETRY, ULTRAVIOLET;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 79960168489
PISSN: 20403364
EISSN: 20403372
Source Type: Journal
DOI: 10.1039/c1nr10278h Document Type: Article |
Times cited : (101)
|
References (33)
|